Remdesivir resistance in renal transplant patients with long COVID-19 researchsquare nyulisom SARSCov2 COVID19 RenalTransplant Remdesivir
By Dr. Priyom Bose, Ph.D.Jul 1 2022Reviewed by Aimee Molineux Scientists have devised various pharmaceutical and non-pharmaceutical strategies to protect individuals from severe acute respiratory syndrome coronavirus-2 , the causal agent of the ongoing coronavirus disease 2019 pandemic.
Remdesivir, a prodrug of the nucleoside analog GS-441524, effectively inhibits the function of RNA-dependent RNA polymerase in multiple RNA viruses. It was the first drug that was approved by the U.S Food and Drug Administration for the treatment of COVID-19. The first patient who received a renal transplant was 60 years of age and had a history of diabetes, vascular disease, and hypertension. The patient underwent a deceased donor kidney transplant after reaching end-stage renal disease . Scientists reported that before the transplant, the patient received two doses of the COVID-19 vaccine . Before the transplant, the patient was subjected to immunosuppressants, such as basiliximab and methylprednisolone.
This patient was also diagnosed with Epstein Barr virus - positive diffuse large B-cell lymphoma , consistent with the monomorphic post-transplant lymphoproliferative disorder and, thereby, chemotherapy was initiated. The patient tested SARS-CoV-2 positive after 110 days after the first COVID-19 diagnosis with Ct of 22.6, and another de novo synonymous mutation in RdRp at K890 was identified.
Implications The current study showed that despite being vaccinated, both patients suffered COVID-19 infection for a prolonged time. Ineffective immune clearance is responsible for persistent viral replication in immunocompromised hosts. This condition also enhances the chances of viral mutation.
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Ischemic stroke risk may be higher after COVID-19 compared to flu or bacterial pneumoniaA new study examined electronic health records for approximately half the population of Denmark, looking for people with a diagnosis of COVID-19 or hospitalized with community-acquired pneumonia.
Read more »
South Korea Approves First Domestically Developed COVID-19 VaccineHealth officials in South Korea on Wednesday approved the country’s first domestically developed COVID-19 vaccine for people 18 years or older, adding another public health tool in the fight against a prolonged pandemic
Read more »
The antiviral effects of thiol drugs in COVID-19The antiviral effects of thiol drugs in COVID-19 APSPhysiology UCSFHospitals COVID19 antiviral coronavirus covid
Read more »
COVID-19 pandemic linked to lower antibodies in breastmilkNew research describes the results of a study measuring such protection and exploring the effects of waning antibody levels on infant susceptibility to respiratory pathogens.
Read more »
COVID-19 Cases Rising Nearly Everywhere in the World, WHO SaysThe number of new coronavirus cases rose by 18% in the last week globally, according to the World Health Organization
Read more »
Why Pregnant People Should Get COVID-19 Vaccines As Soon As PossibleA study suggests that the best way to protect unvaccinated moms-to-be and their fetuses is to vaccinate in the first trimester, then boost in the third.
Read more »